The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksSENS.L Share News (SENS)

  • There is currently no data for SENS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Sensyne Health plunges on liquidation fears

Fri, 14th Jan 2022 11:20

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

----------

AIM - WINNERS

----------

Scotgold Resources Ltd, up 15% at 77.50 pence, 12-month range 46.00p-100.00p. The gold producer says that December brought the company's highest gold concentrate output since its first gold pour. Scotgold upped its production guidance for the first quarter of 2022. Fourth quarter gold production totalled 1,508 ounces at its Cononish gold and silver Mine. Looking forward, Scotgold said it expects its gold production for the first quarter of 2022 to be between 1,400 to 2,200 ounces.

----------

Asiamet Resources Ltd, up 13% at 2.80p, 12-month range 2.00p-5.06p. The exploration and development company announces discovery of "exceptional" grades of gold and silver at its BKZ deposit in Central Kelimantan, Indonesia. Asiamet reports "stunning" findings including 99 metres at 2.42 grams per tonne of gold, 542 grams of silver, and 5.0% lead. This is in addition to the previous findings of high-grade copper and zinc-lead-silver-copper-gold mineralisation at the site.

----------

Quiz PLC, up 14% at 17.90p, 12-month range 6.90p-29.00p. The fashion retailer reports buoyant trading over the festive period against a challenging backdrop for the sector. Quiz posted revenue for December of GBP8.8 million, 20% higher than GBP7.4 million a year before. The increase was in line with the company's guidance.

----------

AIM - LOSERS

----------

Sensyne Health PLC, down 68% at 24.50p, 12-month range 17.00p-190.00p. The healthcare technology shares hit a 12-month low as it warns it will not be able to trade beyond next month without a cash injection. Sensyne announces the signing of a non-binding term sheet with several shareholders for up to GBP12.4 million in funding. The structure of the funding will be a loan note, with the first tranche comprising GBP6.4 million, and a second tranche of GBP5 million, which is subject to mutual consent. Without the funding, it is unlikely that Sensyne will be able to continue to trade beyond early February, it said.

----------

Tower Resources PLC, down 23% at 0.28p, 12-month range 0.21p-0.68p. The oil and gas company raises GBP1.5 million via a new placing of shares, to put towards its African energy projects. Tower Resources issued 576.9 million new ordinary shares at a price of 0.26p per share - a 29% discount to the closing share price on Thursday of 0.37p.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
7 May 2021 19:23

IN BRIEF: Sensyne Health gets UK heath regulator boost

IN BRIEF: Sensyne Health gets UK heath regulator boost

Read more
7 May 2021 08:55

Sensyne's 'MagnifEye' gets MHRA special use authorisation

(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health announced on Friday that its 'MagnifEye' software application, which uses AI to automate the accurate reading and analysis of lateral flow diagnostic tests, has been granted special use authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA).

Read more
30 Apr 2021 14:45

Sensyne Health signs research deal with another NHS trust

(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health has signed a five-year non-exclusive strategic research agreement (SRA) with the Royal Devon and Exeter NHS Foundation Trust, it announced on Friday.

Read more
30 Apr 2021 14:15

TRADING UPDATES: Henry Boot gets planning boost; Beximco sales jump

TRADING UPDATES: Henry Boot gets planning boost; Beximco sales jump

Read more
12 Mar 2021 13:03

IN BRIEF: Sensyne signs deal with UK government to fund Covid tests

IN BRIEF: Sensyne signs deal with UK government to fund Covid tests

Read more
12 Mar 2021 09:23

Sensyne signs £0.5m Covid-19 test deal with DHSC

(Sharecast News) - Clinical artificial intelligence (AI) technology company Sensyne Health has signed a £0.47m agreement with the Department of Health and Social Care, it announced on Friday, to conduct the second stage of a pilot study of its 'MagnifEye' technology for use with Covid-19 lateral flow diagnostic tests.

Read more
1 Mar 2021 16:41

EXECUTIVE CHANGES: New CFOs for Sensyne, Focusrite, Bango, 4D Pharma

EXECUTIVE CHANGES: New CFOs for Sensyne, Focusrite, Bango, 4D Pharma

Read more
1 Mar 2021 15:36

Sensyne Health gets UK approval for 'SYNE-COV' algorithm

(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health announced on Monday that its 'SYNE-COV' machine learning algorithm for Covid-19 risk prediction has achieved regulatory approval for use in the UK.

Read more
1 Mar 2021 15:34

TRADING UPDATES: 1Spatial expects full-year results ahead of forecasts

TRADING UPDATES: 1Spatial expects full-year results ahead of forecasts

Read more
9 Feb 2021 14:43

Sensyne Health signs licence agreement with Excalibur

(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health has signed an exclusive licence and development agreement with Excalibur Healthcare Services, it announced on Tuesday, to apply Sensyne's 'MagnifEye' system for use with Excalibur's proprietary lateral flow rapid diagnostic tests across a range of indications, including its Covid-19 antigen test currently being marketed in the UK and Europe.

Read more
9 Feb 2021 11:18

TRADING UPDATES: Northbridge, discoverIE And Tandem Outlook Upbeat

TRADING UPDATES: Northbridge, discoverIE And Tandem Outlook Upbeat

Read more
5 Feb 2021 12:28

EXECUTIVE CHANGES: Iconic Labs CEO; Tiziana Hires Executive Director

EXECUTIVE CHANGES: Iconic Labs CEO; Tiziana Hires Executive Director

Read more
3 Feb 2021 11:07

IN BRIEF: Sensyne Health Launches AI Algorithm For Patient Management

IN BRIEF: Sensyne Health Launches AI Algorithm For Patient Management

Read more
21 Jan 2021 11:32

Sensyne Health Interim Loss Widens But Boasts Of Commercial Progress

Sensyne Health Interim Loss Widens But Boasts Of Commercial Progress

Read more
20 Jan 2021 19:18

IN BRIEF: Sensyne Health Signs Long-Term Deal With NHS Trust

IN BRIEF: Sensyne Health Signs Long-Term Deal With NHS Trust

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.